OFFICIAL PUBLICATION OF

by its subsidiary APPco

New HIV triple-antiviral on PBS

Megan Haggan 01/04/2015

A new HIV medicine is now available on the PBS to add to the range of treatment options available for people living with HIV in Australia. From 1 April 2015, the new HIV antiviral medication Triumeq (dolutegravir 50mg/abacavir 600mg/lamivudine 300mg) will be available through the PBS. Triumeq is a once daily tablet combing three antiviral

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Recent Comments
Popular Posts

Funding secured for non-8CPA programs

Medschecks and Diabetes MedsCheck are included and funded under the 8CPA. The programs under the 8CPA will be undergoing a…

Anthony Tassone

Eli Lilly clarifies Mounjaro availability

One would think they could have made a commercial decision eith a needle maker to supply requisite number of needles…

Erin Threlfall

Funding secured for non-8CPA programs

This is a big step forward in securing the sustainability and viability of HMRs and RMMRs. Remember there is an…

Debbie Rigby

Funding secured for non-8CPA programs

So well done to the PSA for securing this funding. So important that these very valuable program finally gets looked…

Bente Hart

New HIV triple-antiviral on PBS

Previous Pharmacies contribute to health on the high street

Next Oz pharmaceutical exports declining

Shingles: managing a distressing skin condition

Impetigo: cause and treatment

Topical retinoids: versatile skin care ingredients

Ceramides: what are they and why are they important?

MENU

Previous Pharmacies contribute to health on the high street

Next Oz pharmaceutical exports declining

Related Posts

MENU

Hi there! 👋 Looks like you’re not logged in.